Reata Pharmaceuticals, Inc. Debt to Equity Ratio 2016-2023 | RETA
Current and historical debt to equity ratio values for Reata Pharmaceuticals, Inc. (RETA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Reata Pharmaceuticals, Inc. debt/equity for the three months ending June 30, 2023 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2023-06-30 |
$0.42B |
$0.09B |
4.76 |
2023-03-31 |
$0.58B |
$-0.13B |
-4.47 |
2022-12-31 |
$0.58B |
$-0.07B |
-8.83 |
2022-09-30 |
$0.58B |
$0.01B |
128.24 |
2022-06-30 |
$0.56B |
$0.07B |
8.20 |
2022-03-31 |
$0.55B |
$0.13B |
4.32 |
2021-12-31 |
$0.55B |
$0.19B |
2.95 |
2021-09-30 |
$0.48B |
$0.26B |
1.86 |
2021-06-30 |
$0.46B |
$0.31B |
1.48 |
2021-03-31 |
$0.45B |
$0.37B |
1.21 |
2020-12-31 |
$0.44B |
$0.42B |
1.05 |
2020-09-30 |
$0.43B |
$0.19B |
2.30 |
2020-06-30 |
$0.42B |
$0.23B |
1.82 |
2020-03-31 |
$0.44B |
$0.23B |
1.91 |
2019-12-31 |
$0.43B |
$0.26B |
1.66 |
2019-09-30 |
$0.33B |
$-0.07B |
-4.84 |
2019-06-30 |
$0.33B |
$-0.03B |
-9.98 |
2019-03-31 |
$0.34B |
$-0.01B |
-72.86 |
2018-12-31 |
$0.33B |
$0.02B |
21.77 |
2018-09-30 |
$0.35B |
$0.04B |
9.18 |
2018-06-30 |
$0.34B |
$-0.17B |
-2.04 |
2018-03-31 |
$0.28B |
$-0.14B |
-1.96 |
2017-12-31 |
$0.28B |
$-0.15B |
-1.92 |
2017-09-30 |
$0.29B |
$-0.13B |
-2.21 |
2017-06-30 |
$0.30B |
$-0.23B |
-1.31 |
2017-03-31 |
$0.31B |
$-0.22B |
-1.40 |
2016-12-31 |
$0.30B |
$-0.22B |
-1.41 |
2016-09-30 |
$0.31B |
$-0.21B |
-1.48 |
2016-06-30 |
$0.33B |
$-0.21B |
-1.54 |
2016-03-31 |
$0.34B |
$-0.27B |
-1.24 |
2015-12-31 |
$0.35B |
$-0.27B |
-1.29 |
2015-09-30 |
$0.00B |
|
0.00 |
2015-06-30 |
$0.00B |
|
0.00 |
2015-03-31 |
$0.00B |
|
0.00 |